Cancellation of state registration. Brinerdin

May 2, 2017
Trade names:
ICD-10:
II.D37-D48.D47.3    Essential (hemorrhagic) thrombocythemia
Brinerdin, arterial hypertension, treatment of hypertension, antihypertensive combination drug

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state register of medicines formedical application of the medicinal product (registration certificate P N014211 / 01 of 07.12.2007, issued to Krka, dd, Novo mesto, Slovenia):

Brinerdin (trade name of the medicinal product)

Dihydroergocristine + Clopamid + Reserpine (international non-proprietary or chemical name of the medicinal product)

coated tablets (dosage form, dosage)

KRKA, dd, Novo mesto, Slovenia Smarjeska cesta 6, 8501 Novo mesto, Slovenia (name and address of the location of the manufacturer of the medicinal product)

on the basis of an application by the authorized legal entity of the company "Krka, dd, Novo mesto" to cancel the state registration of the medicinal product.